ba

Baxter International

BAX
NYSE
$19.08

Does Baxter International have high-quality management?

Leadership turned over in 2025: long‑time CEO José Almeida retired in February; director Brent Shafer served as interim CEO, and Andrew Hider (ex‑ATS, Danaher alum) became CEO by August 2025. Hider has a credible operations pedigree and has already initiated continuous‑improvement actions, but his Baxter execution record is nascent and arrives amid quality scrutiny on Novum IQ and hurricane aftereffects.

We give credit for the strategic reset and deleveraging, but reserve judgment until product quality indicators and cash conversion improve sustainably.